• Your easy guide to orphan drug designation for rare diseases

  • Practical tips for designing and conducting an effective rare disease clinical trial

  • How to address the 6 most common pharmacovigilance challenges for MAHs to ensure patient safety in rare disease therapies

  • Your ultimate guide to appointing a marketing authorisation holder